Abstract Body

With 14 million people on ART the push is now to reach the remaining estimated 20 million who are living with HIV, many of whom are undiagnosed. The UNAIDS 90-90-90 target aims for 90% of all people living with HIV to know their status by 2020. 33% more people were tested in 2013 compared with 2009, however it is estimated that over half (54%) of people with HIV are still unaware of their status.
Routine offer of provider initiated testing and counselling (PITC), recommended by WHO since 2007, is widely accepted in ANC and TB services, including in countries with low HIV prevalence, but has not been as well adopted in other clinical settings, even where HIV prevalence is high. This has led to disparities in testing: men, adolescents and people from key populations are less likely to be reached by HTC through clinical services, resulting in lower testing coverage and later access to HIV care. Reliance on testing through clinical services also partly explains the persistent late presentation of people living with HIV to care.
In 2013 WHO recommended that countries expand testing to include a range of community based approaches to overcome PITC limitations. Approaches to reduce structural and legal barriers to community HTC include legitimising lay testing and the use of rapid tests outside clinical settings; exploring effective HIV self-testing models; and reviewing age of consent to support adolescent testing. Recent approaches to increase the proportion of people diagnosed include community-based testing accompanied by geographic prioritization and targeting populations at greatest risk and partner and family testing. Recent evidence also points to several interventions to rationalize and simplify re-testing for those at ongoing risk and better link people to HIV prevention and care.
In response to emerging evidence of significant problems with testing quality, with reports of up to 7% false positive diagnoses of HIV in people being offered ART, WHO re-emphasised its recommendation to all countries to re-test all people before initiating ART. The causes of these misclassifications and measures to reduce them are being explored to avoid the social and public health consequences of misdiagnosis. HTC approaches have evolved and a range of complementary strategies are now available to reach greater numbers of people. HTC is the first step in both accessing care and preventing further transmission. It will be key to achieving global targets.